We are live on
!
Find out more
LSV Asset Management Portfolio holdings
AUM
$55.1B
1-Year Est. Return
45.38%
This Fund
S&P 500
This Quarter
Est. Return
+5.41%
1 Year Est. Return
+45.38%
3 Year Est. Return
+99.45%
5 Year Est. Return
+122.42%
10 Year Est. Return
+379.58%
AUM
$60.6B
AUM Growth
+$4.48B
(+8%)
Cap. Flow
+$1.95B
Cap. Flow
% of AUM
3.22%
Top 10 Holdings %
Top 10 Hldgs %
15.67%
Holding
1,047
New
35
Increased
381
Reduced
346
Closed
48
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
J.M. Smucker
SJM
|
+$164M |
| 2 |
BorgWarner
BWA
|
+$130M |
| 3 |
ESRX
Express Scripts Holding Company
ESRX
|
+$123M |
| 4 |
Gilead Sciences
GILD
|
+$107M |
| 5 |
CVS Health
CVS
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bunge Global
BG
|
+$176M |
| 2 |
Qualcomm
QCOM
|
+$163M |
| 3 |
Boeing
BA
|
+$87.2M |
| 4 |
American Financial Group
AFG
|
+$56.1M |
| 5 |
Ryder
R
|
+$50.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.73% |
| 2 | Technology | 13.69% |
| 3 | Healthcare | 13.65% |
| 4 | Industrials | 10.87% |
| 5 | Consumer Discretionary | 10.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Johnson & Johnson
JNJ
$640B
| $1.28B | 2.11% |
9,818,497
-215,526
| -2% | -$28.6M |
|
2
Pfizer
PFE
$160B
| $1.23B | 2.03% |
36,302,789
+1,230,336
| +4% | +$39.5M |
|
3
JPMorgan Chase
JPM
$942B
| $1.18B | 1.94% |
12,345,368
-23,383
| -0.2% | -$2.16M |
|
4
Citigroup
C
$223B
| $983M | 1.62% |
13,512,104
+491,832
| +4% | +$33.6M |
|
5
Cisco
CSCO
$442B
| $941M | 1.55% |
27,974,705
+521,245
| +2% | +$16.6M |
|
6
Intel
INTC
$487B
| $909M | 1.5% |
23,866,908
+900,658
| +4% | +$32M |
|
7
AT&T
T
$174B
| $806M | 1.33% |
27,233,155
-111,813
| -0.4% | -$3.17M |
|
8
Bank of America
BAC
$428B
| $772M | 1.27% |
30,452,443
+1,849,749
| +6% | +$44.9M |
|
9
Valero Energy
VLO
$99.8B
| $710M | 1.17% |
9,233,881
+157,022
| +2% | +$10.8M |
|
10
ExxonMobil
XOM
$643B
| $697M | 1.15% |
8,505,274
-186,854
| -2% | -$14.8M |
|
|
11
Boeing
BA
$166B
| $669M | 1.1% |
2,632,931
-373,927
| -12% | -$87.2M |
|
12
Amgen
AMGN
$236B
| $668M | 1.1% |
3,580,310
+119,621
| +3% | +$21.2M |
|
13
Verizon
VZ
$205B
| $662M | 1.09% |
13,385,486
+556,193
| +4% | +$26.2M |
|
14
Public Service Enterprise Group
PEG
$36.5B
| $652M | 1.08% |
14,101,249
+304,699
| +2% | +$13.8M |
|
15
Merck
MRK
$369B
| $637M | 1.05% |
10,433,823
+156,068
| +2% | +$9.46M |
|
16
AbbVie
ABBV
$456B
| $608M | 1% |
6,842,773
+214,187
| +3% | +$16.3M |
|
17
Chevron
CVX
$392B
| $587M | 0.97% |
4,999,951
+78,200
| +2% | +$8.54M |
|
18
Elevance Health
ELV
$86.6B
| $514M | 0.85% |
2,707,528
-5,261
| -0.2% | -$1M |
|
|
19
CVS Health
CVS
$119B
| $493M | 0.81% |
6,063,855
+1,180,964
| +24% | +$93.4M |
|
20
Allstate
ALL
$65.1B
| $489M | 0.81% |
5,325,708
+47,058
| +0.9% | +$4.28M |
|
21
Travelers Companies
TRV
$77B
| $488M | 0.8% |
3,982,655
-69,680
| -2% | -$8.7M |
|
22
FedEx
FDX
$78.4B
| $478M | 0.79% |
2,119,586
+229,586
| +12% | +$48.9M |
|
23
FirstEnergy
FE
$26.8B
| $457M | 0.75% |
14,821,910
+383,279
| +3% | +$12.1M |
|
24
Everest Group
EG
$14.5B
| $452M | 0.75% |
1,980,297
+21,860
| +1% | +$5.51M |
|
25
Regions Financial
RF
$25.9B
| $446M | 0.74% |
29,313,283
+1,741,225
| +6% | +$25M |
|
Similar funds
HF
LSV Asset Management's Q3 2017 Portfolio in Review
As of Q3 2017, LSV Asset Management held 1,047 positions worth $60.6B, up 8% from $56.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
LSV Asset Management deployed $1.95B of net new capital in Q3 2017, opening 35 new positions and adding to 381 existing holdings. Its largest new stake was J.M. Smucker: 1,437,276 shares worth $151M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Bunge Global, an estimated $176M trimmed.
- LSV Asset Management's largest Q3 2017 buy was J.M. Smucker: 1,437,276 shares worth $151M.
- LSV Asset Management added most to BorgWarner in Q3 2017, an estimated $130M increase.
- LSV Asset Management's biggest Q3 2017 reduction was Bunge Global, cutting an estimated $176M.
- LSV Asset Management fully exited Opus Bank Common Stock in Q3 2017, selling an estimated $11.3M.
- LSV Asset Management's ten largest holdings make up 16% of its $60.6B portfolio in Q3 2017.
- LSV Asset Management opened 35 new positions and closed 48 in Q3 2017.
- LSV Asset Management's portfolio value rose 8% quarter-over-quarter to $60.6B.
Based on LSV Asset Management's 13F filing for Q3 2017, filed 13 Nov 2017.